Molecular Diagnostics Market Analysis By Products & By Technology 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Molecular diagnostics market
Molecular Diagnostics Market: By Products (Analyzers, Reagents) Technology (PCR, INAAT, Hybridization, DNA Sequencing Others) End Users (Hospitals, Clinical Laboratories, Academics) Applications (Oncology, Microbiology, Others)-Forecast(2015-2020)
Report Code : HCR 0068
Published: 26 May, 2015   No. of pages: 73

  • Report Description
  • Table of Contents
  • Customization Options
Molecular Diagnostics is a diasnosis technique that utilizes DNA, RNA and proteins to detect specific health condition or diseases. Molecular Diagnostics represents enormous market growth of in-vitro diagnostics and now-a-days routinely used in hospitals, reference labs, and blood banks.

The molecular diagnostics market report gives an in-depth segmentation of the market by products, technology and applications. It also segmented by end user verticals and key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analyzed in great detail in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided.

The prominent players profiled in the molecular diagnostics market report are:
  • Abbott Diagnostics
  • Beckman Coulter
  • Becton
  • Dickinson & Co
  • Biomérieux.
The report contains the most detailed and in-depth segmentation of the global Molecular Diagnostics market.
1. Molecular Diagnostics  Market Overview
2. Executive Summary
3. Molecular Diagnostics  Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Molecular Diagnostics  Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Molecular Diagnostics Market Government Regulations
6. Molecular Diagnostics Market Strategic Analysis
   6.1. Value Chain Analysis
   6.2. Pricing Analysis
   6.3. Opportunities Analysis
   6.4. Product/Market Life Cycle Analysis
7. Molecular Diagnostics Market By Products
   7.1. Analyzers
   7.2. Reagents
8. Molecular Diagnostics Market By Technology
   8.1. PCR
   8.2. INAAT
   8.3. Hybridization
   8.4. DNA Sequencing and Next Generation Sequencing
   8.5. Microarray
   8.6. Spectral Karyotype Imaging (SKI)
   8.7. Others
9. Molecular Diagnostics Market By End Users
   9.1. Hospitals
   9.2. Clinical Laboratories
   9.3. Academics
10.  Molecular Diagnostics - Market By Applications
   10.1. Infectious Disease
      10.1.1. HBV
      10.1.2. HCV
      10.1.3. HIV
      10.1.4. TB
      10.1.5. CT/NG
      10.1.6. HPV
      10.1.7. MRSA
      10.1.8. Others
   10.2. Oncology
      10.2.1. Prostate Cancer
      10.2.2. Breast Cancer
      10.2.3. Colorectal Cancer
      10.2.4. Others
   10.3. Genetic Disease Screening
   10.4. Blood Screening
   10.5. Microbiology
   10.6. Others
11.  Molecular Diagnostics - Market Geographic Analysis
   11.1. Americas
   11.2. Europe
   11.3. APAC
   11.4. ROW
12.  Market Entropy
   12.1. New Product Launches
   12.2. M&As, Collaborations, JVs and Partnerships
13.  Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
   13.1. Abbott Diagnostics, Inc.
   13.2. Beckman Coulter, Inc.
   13.3. Becton, Dickinson & Co.
   13.4. Biomérieux
   13.5. Cepheid, Inc.
   13.6. Gen-Probe, Inc. (Hologic, Inc.)
   13.7. Novartis AG
   13.8. Qiagen N.V.
   13.9. F. Hoffmann-La Roche Ltd.
   13.10. Siemens Healthcare
   13.11. Myriad Genetics, Inc.
   13.12. Danaher Corporation
   13.13. Bio-Rad Laboratories, Inc.
   13.14. Quest Diagnostics, Inc.
   13.15. Thermo Fisher Scientific
   13.16. Johnson and Johnson
   13.17. Sysmex
   13.18. Bayer Healthcare AG
   13.19. Alere Inc.
   13.20. Leica Biosystems
   13.21. Agilient Technologies, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14.  Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
   14.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports